The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

Stepan Reports Higher Second Quarter Earnings, Up 22%

Wednesday, July 27, 2011

Stepan Reports Higher Second Quarter Earnings, Up 22%08:00 EDT Wednesday, July 27, 2011NORTHFIELD, Ill., July 27, 2011 /PRNewswire/ -- Stepan Company (NYSE: SCL) today reported higher second quarter and year-to-date results for the period ended June 30, 2011. Net income rose 22 percent to $20.9 million compared to $17.0 million a year ago.  Earnings per share also rose 22 percent to $1.87 per share.Net income, excluding deferred compensation plan expense, was $20.7 million compared to $19.2 million a year ago, up eight percent.Net sales rose 30 percent primarily due to higher selling prices.  Gross profit rose 10 percent despite commodity raw material inflation.  Total sales volume grew by less than one percent as six percent higher polymer volumes were offset by a one percent decrease in surfactant volumes.SUMMARYThree Months Ended June 30Six Months Ended June 30($ in thousands, except per share amounts)20112010% Change20112010% ChangeNet Sales$476,989$366,504+ 30$899,587$703,534+ 28Net Income20,86717,046+ 2239,62837,706+ 5Net Income Excluding   Deferred Compensation*20,68019,163+ 838,90438,490+ 1Earnings per Diluted Share$1.87$1.53+ 22$3.55$3.41+ 4Earnings per Diluted Share   Excluding Deferred   Compensation$1.85$1.72+ 8$3.49$3.48?*  See Table II for a discussion of deferred compensation plan accounting.SECOND QUARTER RESULTSThree Months Ended June 30Six Months Ended June 30($ in thousands)20112010% Change20112010% ChangeNet Sales   Surfactants$343,767$264,567+ 30$668,652$526,880+ 27   Polymers120,85490,893+ 33207,253154,003+ 35   Specialty Products12,36811,044+ 1223,68222,651+ 5       Total Net Sales$476,989$366,504+ 30$899,587$703,534+ 28Net sales rose by 30 percent due to higher selling prices (25 percent) and the effect of foreign currency translation (five percent).  Sales volume grew by less than one percent.  A six percent increase in polymer sales volume was largely offset by a one percent decline in surfactant volume.Surfactant sales volume declined by one percent due to weaker volumes in Consumer Products partially offset by improved sales in the Agricultural and Oil Field segments.   Oil Field volume improvement was driven by increased sales into EOR applications.Polymer sales volume rose six percent.  Sales volume of polyol, used primarily in rigid foam insulation rose by 12 percent.  External sales of phthalic anhydride (PA) declined by 10 percent, while profitability improved on higher margins.  The lower PA volume relates to recurring weakness in polyester resins used in automotive, boating and construction industries.  Internal consumption of PA increased on higher polyol volumes.Gross profit increased by 10 percent to $69.6 million versus $63.5 million a year ago.Surfactant gross profit rose by $1.5 million, or three percent, due to a more favorable sales mix in North America and Europe that was partially offset by lower Consumer Product sales.  Latin American gross profit declined due to higher expenses associated with our Brazilian expansion.  Latin American volume grew by 22 percent.Polymer gross profit surged 37 percent to $20.6 million compared to $15.0 million a year ago.  The improvement was largely due to the 12 percent increase in polyol volume coupled with improved margins, particularly in Europe, which had experienced margin erosion over the last year as commodity raw material costs escalated.  We anticipate continued strong demand for polyol used in replacement roofs driven by energy savings and expanded use in metal panel applications.Specialty Products gross profit declined four percent to $4.4 million versus $4.6 million a year ago.  The decrease is due to lower margins in our food ingredient business precipitated by higher raw material costs and competitive pressure on selling prices.  Sales volume rose eight percent.OPERATING EXPENSESThree Months Ended June 30Six Months Ended June 30($ in thousands)20112010% Change20112010% ChangeMarketing   $12,171    $9,391   + 30   $23,001   $20,342   + 13Administrative ? General    13,008    11,543   + 13    24,263    22,407    + 8Administrative ? Deferred  Compensation     (328)     2,730    NM     (709)       929    NMResearch, development  and technical service     10,656     10,042    + 6      20,887      19,925    + 5    Total   $35,507   $33,706    + 5   $67,442   $63,603    + 6Marketing expense rose 30 percent for the quarter and 13 percent year-to-date.  Investments planned to accelerate growth in Singapore, Brazil and Poland and the consolidation of the Philippine operation accounted for nearly half of the growth in marketing expense.  Higher travel expense and the effect of foreign currency translation of expenses incurred outside the U.S. contributed to the remaining increase.Administrative general expense rose by 13 percent for the quarter and eight percent for the year.  The growth initiatives in Singapore, Brazil and Poland contributed to the increase coupled with the effect of foreign currency translation.INCOME TAXESThe effective tax rate was 33 percent for the quarter and 32 percent for the year-to-date period compared to 35 percent in the year ago periods.  The decrease was primarily attributable to the implementation of a holding company structure that will provide a recurring benefit in lowering the effective tax rate on foreign earnings.BALANCE SHEETThe Company's net debt levels increased by $32.2 million for the quarter and increased $84.8 million for the first six months:($in millions)Net Debt6/30/113/31/1112/31/10   Total Debt$190.8$185.7$191.6   Cash25.652.7111.2   Net Debt$165.2$133.0$80.4The year-to-date increase in net debt was primarily due to the inflationary impact of higher commodity raw material costs on inventory and receivables. The second quarter increase also included the Lipid Nutrition product line acquisition, including inventory. Capital expenditures for the quarter and year-to-date periods were $17.9 million and $40.4 million, respectively.OUTLOOKOur growth initiatives are on track to deliver future earnings in 2012.  Surfactant earnings will improve this year as growth from our higher margin functional surfactants offset the weakness in consumer volumes.  Surfactant demand for enhanced oil recovery continues to grow.  Our Brazil expansion is complete and we will have improved contribution in the third quarter.  The significant improvement in our Polymer business this year is in line with our expectations.  The sold out demand for polyol at our German plant will continue to require imports from our Illinois plant for the balance of the year due to delays in the expanded German capacity.  Our polymer plant in Poland should see improved volume over the balance of the year as we begin fulfilling new customer demand.Specialty Product earnings will benefit from our recently announced Lipid Nutrition product line acquisition.  The acquisition should contribute to earnings this year and provide longer term synergies with our existing food ingredient business.While 2011 will have some planned higher costs associated with our global growth initiatives, we have the opportunity to deliver full year earnings growth. CONFERENCE CALLStepan Company will host a conference call to discuss the second quarter results at 1:00 p.m. Eastern Daylight Time on July 27, 2011. To listen to a live webcast of this call, please go to our Internet website at:, click on investor relations, next click on conference calls and follow the directions on the screen.Stepan Company, headquartered in Northfield, Illinois, is a leading producer of specialty and intermediate chemicals used in household, industrial, personal care, agricultural, food and insulation related products.  The common and the convertible preferred stocks are traded on the New York and Chicago Stock Exchanges under the symbols SCL and SCLPR.* * * * *tables followExcept for historical information, all other information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied.  The most significant of these uncertainties are described in Stepan Company's Form 10-K, Form 8-K and Form 10-Q reports and exhibits to those reports, and include (but are not limited to), prospects for our foreign operations, foreign currency fluctuations, certain global and regional economic conditions, the probability of future acquisitions and the uncertainties related to the integration of acquired businesses, the probability of new products, the loss of one or more key customer or supplier relationships, the costs and other effects of governmental regulation and legal and administrative proceedings, including the expenditures necessary to address and resolve environmental claims and proceedings, and general economic conditions.  These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.Table ISTEPAN COMPANYStatements of IncomeFor the Three and Six Months Ended June 30, 2011 and 2010(Unaudited ? 000's Omitted)Three Months EndedJune 30Six Months EndedJune 3020112010% Change20112010% ChangeNet Sales$476,989$366,504 +   30$899,587$703,534 +   28Cost of Sales  407,404303,026 +   34768,216576,504 +   33   Gross Profit69,58563,478 +   10131,371127,030 +    3Operating Expenses:   Marketing12,1719,391 +   3023,00120,342 +   13   Administrative12,68014,273 -   1123,55423,336 +    1   Research, development       and technical services  10,656  10,042 +    6 20,887 19,925 +    535,50733,706 +    567,44263,603 +    6Operating Income34,07829,772 +   1463,92963,427 +    1Other Income (Expense):   Interest, net(2,194)(1,510) +   45(4,257)(2,766) +   54   Loss from equity in joint ventures    (805)    (764) +    5    (1,770)    (1,335) +   33   Other, net     253     (1,111)    NM    565    (1,333)    NM(2,746)(3,385) -   19(5,462)(5,434) +    1Income before Income Taxes 31,33226,387 +   1958,46757,993 +    1Provision for Income Taxes 10,326  9,318 +   11  18,645  20,243 -     8Net Income21,00617,069 +   2339,82237,750 +    5Add: Net Income Attributable to the Noncontrolling Interests      (139)       (23) +  504        (194)        (44) +  341Net Income Attributable to   Stepan Company$20,867$17,046 +   22$39,628$37,706 +    5Net Income Per Common ShareAttributable to Stepan Company   Basic$2.00$1.66 +   20$3.80$3.69 +    3   Diluted$1.87$1.53 +   22$3.55$3.41 +    4Shares Used to Compute Net Income Per Common Share Attributable to Stepan Company   Basic10,34510,160 +    210,33510,130 +    2   Diluted11,17811,118 +    111,17511,052 +    1Table IIDeferred Compensation PlanThe full effect of the deferred compensation plan on quarterly pretax income was $0.3 million of income versus expense of $3.4 million last year.  The accounting for the deferred compensation plan results in income when the price of Stepan Company common stock or mutual funds held in the plan fall and expense when they rise.  The Company also recognizes the change in value of mutual funds as investment income or loss.  The deferred compensation expense income statement impact is summarized below:Three Months Ended June 30Six Months Ended June 30($in thousands)2011201020112010Deferred Compensation   Administrative (Expense) Income$328$(2,730)$709$(929)   Other, net ? Mutual Fund Gain (Loss)(26)(685)460(336)       Total Pretax$302$(3,415)$1,169$(1,265)       Total After Tax$187$(2,117)$724$(784)Reconciliation of non-GAAP net income:Three Months Ended June 30Six Months Ended June 30($ in thousands)2011201020112010Net income excluding deferred   compensation$20,680$19,163$38,904$38,490Deferred compensation plan (expense)   income        187     (2,117)       724       (784)Net income as reported$20,867$17,046$39,628$37,706Reconciliation of non-GAAP EPS:Three Months Ended June 30Six Months Ended June 302011201020112010Earnings per diluted share excluding   deferred compensation$1.85$1.72$3.49$3.48Deferred compensation plan (expense)   income  0.02(0.19)    0.06 (0.07)Earnings per diluted share$1.87$1.53$3.55$3.41The Company believes that certain non-GAAP measures, when presented in conjunction with comparable GAAP (Generally Accepted Accounting Principles) measures, are useful because that information is an appropriate measure for evaluating the Company's operating performance.  Internally, the Company uses this non-GAAP information as an indicator of business performance, and evaluates management's effectiveness with specific reference to these indicators.  These measures should be considered in addition to, neither a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP.Table IIIEffects of Foreign Currency TranslationThe Company's foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e. because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results). For the second quarter and the first half of 2011, the U.S. dollar was weaker against all the foreign currencies in the locations where the Company does business, when compared to the exchange rates for the second quarter and first half of 2010. Consequently, reported net sales, expense and income amounts for 2011 were higher than they would have been had the foreign currency exchange rates remained constant with the rates for 2010. Below is a table that presents the effect that foreign currency translation had on the quarter-over-quarter and year-over-year changes in consolidated net sales and various income line items for the second quarter and first half ending June 30, 2011: Three Months Ended June 3020112010IncreaseIncrease Due toForeign TranslationNet Sales$477.0$366.5110.516.6Gross Profit69.663.56.11.5Operating Income34. Income31.326.44.90.4Six MonthsEnded June 3020112010IncreaseIncrease Due toForeign TranslationNet Sales$899.6$703.5196.120.1Gross Profit131.4127.04.41.9Operating Income63.963.40.50.9Pretax Income58.558.00.50.6Table IVStepan CompanyConsolidated Balance SheetsJune 30, 2011 and December 31, 20102011June 302010December 31ASSETSCurrent Assets$504,592$427,826Property, Plant & Equipment, Net368,766353,585Other Assets37,56730,020   Total Assets$910,925$811,431LIABILITIES AND STOCKHOLDERS' EQUITYCurrent Liabilities$262,534$205,627Deferred Income Taxes9,9865,154Long-term Debt154,956159,963Other Non-current Liabilities82,46287,616Total Stepan Company Stockholders' Equity397,171349,491Minority Interest3,8163,580   Total Liabilities and Stockholders' Equity$910,925$811,431SOURCE Stepan CompanyFor further information: James E. Hurlbutt, +1-847-446-7500